132 related articles for article (PubMed ID: 17965488)
1. Hypoadiponectinemia is associated with impaired glucose tolerance and coronary artery disease in non-diabetic men.
Otsuka F; Sugiyama S; Kojima S; Maruyoshi H; Funahashi T; Sakamoto T; Yoshimura M; Kimura K; Umemura S; Ogawa H
Circ J; 2007 Nov; 71(11):1703-9. PubMed ID: 17965488
[TBL] [Abstract][Full Text] [Related]
2. High sensitive C-reactive protein, adiponectin, and urine albumin excretion rate in Chinese coronary artery disease patients with different glucose tolerance status.
Gui MH; Hong J; Lü AK; Chen Y; Shen WF; Li XY; Ning G
Chin Med J (Engl); 2008 Dec; 121(24):2509-16. PubMed ID: 19187587
[TBL] [Abstract][Full Text] [Related]
3. Leptin-adiponectin ratio in pre-diabetic patients undergoing percutaneous coronary intervention.
Nguyen PA; Heggermont WA; Vanhaverbeke M; Dubois C; Vydt T; Vörös G; Van Der Schueren B; Overbergh L; Mathieu C; Desmet W; Sinnaeve PR
Acta Cardiol; 2015 Dec; 70(6):640-6. PubMed ID: 26717211
[TBL] [Abstract][Full Text] [Related]
4. Relationship of visceral fat distribution to angiographically assessed coronary artery disease: results in subjects with or without diabetes or impaired glucose tolerance.
Morricone L; Donati C; Hassan T; Cioffi P; Caviezel F
Nutr Metab Cardiovasc Dis; 2002 Oct; 12(5):275-83. PubMed ID: 12616807
[TBL] [Abstract][Full Text] [Related]
5. Adiponectin and insulin resistance are related to restenosis and overall new PCI in subjects with normal glucose tolerance: the prospective AIRE Study.
Sasso FC; Pafundi PC; Marfella R; Calabrò P; Piscione F; Furbatto F; Esposito G; Galiero R; Gragnano F; Rinaldi L; Salvatore T; D'Amico M; Adinolfi LE; Sardu C
Cardiovasc Diabetol; 2019 Mar; 18(1):24. PubMed ID: 30832662
[TBL] [Abstract][Full Text] [Related]
6. Adiponectin isoforms are not associated with the severity of coronary atherosclerosis but with undiagnosed diabetes in patients affected by stable CAD.
Rizza S; Clementi F; Porzio O; Cardellini M; Savo A; Serino M; Chiricolo G; Romeo F; Lauro R; Federici M
Nutr Metab Cardiovasc Dis; 2009 Jan; 19(1):54-60. PubMed ID: 18472407
[TBL] [Abstract][Full Text] [Related]
7. Association of hypoadiponectinemia with coronary artery disease in men.
Kumada M; Kihara S; Sumitsuji S; Kawamoto T; Matsumoto S; Ouchi N; Arita Y; Okamoto Y; Shimomura I; Hiraoka H; Nakamura T; Funahashi T; Matsuzawa Y;
Arterioscler Thromb Vasc Biol; 2003 Jan; 23(1):85-9. PubMed ID: 12524229
[TBL] [Abstract][Full Text] [Related]
8. Gender differences in screening for glucose perturbations, cardiovascular risk factor management and prognosis in patients with dysglycaemia and coronary artery disease: results from the ESC-EORP EUROASPIRE surveys.
Ferrannini G; De Bacquer D; Vynckier P; De Backer G; Gyberg V; Kotseva K; Mellbin L; Norhammar A; Tuomilehto J; Wood D; Rydén L;
Cardiovasc Diabetol; 2021 Feb; 20(1):38. PubMed ID: 33573665
[TBL] [Abstract][Full Text] [Related]
9. Impact of abnormal glucose tolerance, hypertension and other risk factors on coronary artery disease.
Nakamura Y; Saitoh S; Takagi S; Ohnishi H; Chiba Y; Kato N; Akasaka H; Miura T; Tsuchihashi K; Shimamoto K
Circ J; 2007 Jan; 71(1):20-5. PubMed ID: 17186973
[TBL] [Abstract][Full Text] [Related]
10. Postchallenge responses of nitrotyrosine and TNF-alpha during 75-g oral glucose tolerance test are associated with the presence of coronary artery diseases in patients with prediabetes.
Chu CS; Lee KT; Cheng KH; Lee MY; Kuo HF; Lin TH; Su HM; Voon WC; Sheu SH; Lai WT
Cardiovasc Diabetol; 2012 Mar; 11():21. PubMed ID: 22397368
[TBL] [Abstract][Full Text] [Related]
11. High plasma levels of macrophage migration inhibitory factor are associated with adverse long-term outcome in patients with stable coronary artery disease and impaired glucose tolerance or type 2 diabetes mellitus.
Makino A; Nakamura T; Hirano M; Kitta Y; Sano K; Kobayashi T; Fujioka D; Saito Y; Watanabe K; Watanabe Y; Kawabata K; Obata JE; Kugiyama K
Atherosclerosis; 2010 Dec; 213(2):573-8. PubMed ID: 20934703
[TBL] [Abstract][Full Text] [Related]
12. Decreased plasma concentration of a novel anti-inflammatory protein--adiponectin--in hypertensive men with coronary artery disease.
Dzielińska Z; Januszewicz A; Wiecek A; Demkow M; Makowiecka-Cieśla M; Prejbisz A; Kadziela J; Mielniczuk R; Florczak E; Janas J; Januszewicz M; Ruzyłło W
Thromb Res; 2003 Jun; 110(5-6):365-9. PubMed ID: 14592564
[TBL] [Abstract][Full Text] [Related]
13. Letter by Oda et al regarding article, "Hypoadiponectinemia is associated with impaired glucose tolerance and coronary artery disease in non-diabetic men".
Oda E; Watanabe K
Circ J; 2008 Mar; 72(3):505; author reply 506-7. PubMed ID: 18296857
[No Abstract] [Full Text] [Related]
14. Predicting persistent impaired glucose tolerance in patients with gestational diabetes: The role of high sensitivity CRP and adiponectin.
Durnwald CP; Downes K; Leite R; Elovitz M; Parry S
Diabetes Metab Res Rev; 2018 Feb; 34(2):. PubMed ID: 29078256
[TBL] [Abstract][Full Text] [Related]
15. Association of serum adiponectin levels and coronary flow reserve in women with normal coronary angiography.
Eroglu S; Sade LE; Bozbas H; Haberal A; Ozbicer S; Demir O; Muderrisoglu H
Eur J Cardiovasc Prev Rehabil; 2009 Jun; 16(3):290-6. PubMed ID: 19404197
[TBL] [Abstract][Full Text] [Related]
16. The prediction roles of asymmetric dimethyl-arginine, adiponectin and apelin for macroangiopathy in patients with impaired glucose regulation.
Huang S; Zou D; Peng W; Jiang X; Shao K; Xia L; Tang Y
Ann Endocrinol (Paris); 2016 Dec; 77(6):633-640. PubMed ID: 27641081
[TBL] [Abstract][Full Text] [Related]
17. Plaque Characteristics in Coronary Artery Disease Patients with Impaired Glucose Tolerance.
Suzuki K; Takano H; Kubota Y; Inui K; Nakamura S; Tokita Y; Kato K; Asai K; Shimizu W
PLoS One; 2016; 11(12):e0167645. PubMed ID: 27936195
[TBL] [Abstract][Full Text] [Related]
18. Transient impaired glucose tolerance in South African Indians does not carry a risk for progression to NIDDM.
Motala AA; Omar MA; Gouws E
Diabetes Care; 1997 Jul; 20(7):1101-7. PubMed ID: 9203444
[TBL] [Abstract][Full Text] [Related]
19. Comparison of plasma adiponectin & certain inflammatory markers in angiographically proven coronary artery disease patients with & without diabetes--a study from India.
Kumpatla S; Karuppiah K; Immaneni S; Muthukumaran P; Krishnan J; Narayanamoorthy SK; Viswanathan V
Indian J Med Res; 2014 Jun; 139(6):841-50. PubMed ID: 25109718
[TBL] [Abstract][Full Text] [Related]
20. Pravastatin improved glucose metabolism associated with increasing plasma adiponectin in patients with impaired glucose tolerance and coronary artery disease.
Sugiyama S; Fukushima H; Kugiyama K; Maruyoshi H; Kojima S; Funahashi T; Sakamoto T; Horibata Y; Watanabe K; Koga H; Sugamura K; Otsuka F; Shimomura I; Ogawa H
Atherosclerosis; 2007 Oct; 194(2):e43-51. PubMed ID: 17112529
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
